Novartis launches Scapho for the treatment of moderate-to-severe psoriasis in India
Novartis Healthcare Private Limited (NHPL) announced the launch of Scapho (secukinumab) 150 mg, for the treatment of moderate-to-severe plaque psoriasis in adult patients. […]






